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A B S T R A C T
Background
Identification of the causes of stillbirth is critical to the primary prevention of stillbirth and to the provision of optimal care in subsequent
pregnancies. A wide variety of investigations are available, but there is currently no consensus on the optimal approach. Given their
cost and potential to add further emotional burden to parents, there is a need to systematically assess the effect of these interventions
on outcomes for parents, including psychosocial outcomes, economic costs, and on rates of diagnosis of the causes of stillbirth.
Objectives
To assess the effect of different tests, protocols or guidelines for investigating and identifying the causes of stillbirth on outcomes for
parents, including psychosocial outcomes, economic costs, and rates of diagnosis of the causes of stillbirth.
Search methods
We searched Cochrane Pregnancy and Childbirth’s Trials Register (31 August 2017), ClinicalTrials.gov and the WHO International
Clinical Trials Registry Platform (ICTRP) (15 May 2017).
Selection criteria
We planned to include randomised controlled trials (RCTs), quasi-RCTs, and cluster-RCTs. We planned to include studies published
as abstract only, provided there was sufficient information to allow us to assess study eligibility. We planned to exclude cross-over trials.
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Participants included parents (including mothers, fathers, and partners) who had experienced a stillbirth of 20 weeks’ gestation or
greater.
This review focused on interventions for investigating and identifying the causes of stillbirth. Such interventions are likely to be diverse,
but could include:
* review of maternal and family history, and current pregnancy and birth history;
* clinical history of present illness;
* maternal investigations (such as ultrasound, amniocentesis, antibody screening, etc.);
* examination of the stillborn baby (including full autopsy, partial autopsy or noninvasive components, such as magnetic resonance
imaging (MRI), computerised tomography (CT) scanning, and radiography);
* umbilical cord examination;
* placental examination including histopathology (microscopic examination of placental tissue); and
* verbal autopsy (interviews with care providers and support people to ascertain causes, without examination of the baby).
We planned to include trials assessing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for investigating
the causes of stillbirth, compared with the absence of a test, protocol or guideline, or usual care (further details are presented in the
Background, see Description of the intervention).
We also planned to include trials comparing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for inves-
tigating the causes of stillbirth with another, for example, the use of a limited investigation protocol compared with a comprehensive
investigation protocol.
Data collection and analysis
Two review authors assessed trial eligibility independently.
Main results
We excluded five studies that were not RCTs. There were no eligible trials for inclusion in this review.
Authors’ conclusions
There is currently a lack of RCT evidence regarding the effectiveness of interventions for investigating and identifying the causes of
stillbirth. Seeking to determine the causes of stillbirth is an essential component of quality maternity care, but it remains unclear what
impact these interventions have on the psychosocial outcomes of parents and families, the rates of diagnosis of the causes of stillbirth,
and the care and management of subsequent pregnancies following stillbirth. Due to the absence of trials, this review is unable to
inform clinical practice regarding the investigation of stillbirths, and the specific investigations that would determine the causes.
Future RCTs addressing this research question would be beneficial, but the settings in which the trials take place, and their design,
need to be given careful consideration. Trials need to be conducted with the utmost care and consideration for the needs, concerns,
and values of parents and families. Assessment of longer-term psychosocial variables, economic costs to health services, and effects on
subsequent pregnancy care and outcomes should also be considered in any future trials.
P L A I N L A N G U A G E S U M M A R Y
Interventions for investigating and identifying the causes of stillbirth
What is the issue?
There are many causes of stillbirth, including the mother having high blood pressure or diabetes before the pregnancy, an infection
such as malaria, HIV or syphilis, congenital abnormalities in the baby, issues with how well the placenta is functioning, and pregnancy
continuing past the due date. Sometimes a baby dies as a result of multiple causes. The death of a baby to stillbirth is a devastating
event for parents, families, and communities. To prevent stillbirths, we need to understand more about why they occur. Understanding
why a baby died may also help parents to cope with their grief, and assist them in care planning for future pregnancies.
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Many different tests and investigations can be done to help find out why a baby died. These tests and investigations differ in the level of
expertise required, how invasive they are, and their economic costs. Tests, procedures or guidelines for investigating and identifying the
causes of stillbirth include looking at the medical history of the parents, any problems during the pregnancy, maternal investigations
(such as ultrasound, amniocentesis, antibody screening), examination of the stillborn baby, examination of the umbilical cord and
placenta, and interviews with care providers and support people to determine causes without examination of the baby (verbal autopsy).
Currently there is no standard approach to investigating the causes of stillbirth.
Why is this important?
Searching for causes of stillbirth can be difficult emotionally for families, and financially costly to health services and sometimes to
parents. Some tests and investigations may be more helpful than others in identifying the causes of stillbirth. There is a need to assess
systematically which approaches are most helpful in finding causes of stillbirth, how cost-effective the different approaches are, what
the emotional and social effects on parents are, what impact the investigations have on future pregnancies, and the end result of future
pregnancies.
What evidence did we find?
We searched for evidence on 15 May 2017. We did not find any trials for inclusion in this review. We excluded five trials because they
were not randomised controlled trials.
What does this mean?
There is no evidence available to guide how best to investigate the causes of stillbirth. Seeking to determine the causes of a baby’s
death is an essential component of quality maternity care in any setting. Future trials on this topic would be helpful, but such trials
would need to be designed in a way that ensures all parents in the trial still receive the minimum standard of care in their local setting.
Future trials would need to be conducted with the utmost care and consideration for the needs, concerns, and values of parents and
families. Assessment of longer-term psychosocial variables, economic costs to health services, and effects on subsequent pregnancy care
and outcomes should be considered in any future trials.
B A C K G R O U N D
Description of the condition
Stillbirth is associated with profound and long-lasting adverse psy-
chosocial outcomes for families and care providers, along with
wider economic impacts on health systems and society (Heazell
2016). The global burden of stillbirth is high, with an estimated
2.6 million stillbirths (at 28 weeks’ gestation or greater) occurring
every year. Although many of these deaths are preventable, global
reduction in stillbirth rates remains slow and has not matched de-
clines in maternal or child mortality (Lawn 2016).
Accurate data on causes of stillbirth are limited, partly due to
the difficulty in assigning causation, often owing to multifacto-
rial circumstances (Silver 2007; Whitfield 1986). The use of var-
ious, disparate classification systems for assigning cause of death
also hampers understanding of causes at global and regional levels
(Flenady 2015; Flenady 2017; Leisher 2016; Wojcieszek 2016).
Flenady 2016 showed wide variation in the contribution of differ-
ent causes of stillbirth. For example, the proportion of stillbirths
related to infection ranged from 5% to 22%, and the proportion
of stillbirths related to congenital abnormalities ranged from 6%
to 27%. “Unexplained” deaths were reported for up to 76% of
cases, and showed particularly wide variation. In a global review
of 85 national stillbirth reports across 50 countries, “unexplained”
was the most commonly reported cause of death category among
the 489,089 stillbirths included (Reinebrant 2017).
Difficulties ascertaining causes of death are often compounded
by limited availability of clinical information. In some low- and
middle-income countries (LMICs), minimal or no diagnostic in-
vestigations are available (Flenady 2010; McClure 2018). Many
stillbirths are not reported, especially among the large proportion
of births occurring outside formal health services. Despite these
limitations, it is clear that over half of stillbirths (globally) are re-
lated to intrapartum complications, and that increased access to
skilled birth attendants and emergency obstetric care could elimi-
nate most of these deaths (Lawn 2016). Infections such as malaria
and syphilis and placental conditions such as poor growth of the
baby (also called fetal growth restriction (FGR)), placental abrup-
tion (when the placenta breaks away from the wall of the uterus),
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and pre-eclampsia (high blood-pressure and protein in the urine)
are other commonly reported causes of stillbirth. Pre-existing hy-
pertension and pre-existing diabetes are also common, important
risk factors for stillbirth. These risk factors are often associated
with obesity and maternal age over 35 years, which are indepen-
dent risk factors for stillbirth that are also increasingly common
throughout the developed and developing worlds (Flenady 2011).
Other major risk factors for stillbirth include smoking, primipar-
ity (where a woman is giving birth for the first time), multiple
pregnancy, previous stillbirth (Flenady 2011), and post-term preg-
nancy (Flenady 2011; Lawn 2016).
Although the burden of stillbirth lies predominantly in LMICs,
thousands of potentially preventable stillbirths also occur in high-
income countries (HICs) (Flenady 2016). In these settings, most
stillbirths occur in the antenatal period, and are associated with
placental dysfunction (Flenady 2016).Disparities in stillbirth rates
are clearly evident, with the risk of stillbirth among disadvantaged
women roughly double that of more advantaged women (Flenady
2016).
Description of the intervention
Accurate determination of causes and contributing factors is
needed to reduce stillbirth rates. To identify causes of death, col-
lection of data related to the stillbirth, such as demographic data,
maternal risk factors and labour and birth information are required
(Barfield 2011; Flenady 2018). A range of investigations, as de-
scribed in further detail below, may also be used.
This review focused on interventions for investigating and iden-
tifying the causes of stillbirth. Such interventions are diverse, but
may include:
• review of maternal and family history, and current
pregnancy and birth history;
• clinical history of present illness;
• maternal investigations (such as ultrasound, amniocentesis,
antibody screening, etc);
• examination of the stillborn baby (including full autopsy,
partial autopsy or noninvasive components, such as magnetic
resonance imaging (MRI), computerised tomography (CT)
scanning, and radiography);
• umbilical cord examination;
• placental examination including histopathology
(microscopic examination of placental tissue); and
• verbal autopsy (interviews with care providers and support
people to ascertain causes, without examination of the baby).
Among the investigations available to parents and clinicians, au-
topsy is considered the ’gold standard’ in determining causes of
death (Alderliesten 2003; Lyon 2004; Rose 2006). Autopsy can
identify a wide range of causes of stillbirth, including infection,
anaemia, and morphologic (structural) and metabolic (relating to
metabolism) abnormalities (Silver 2007). However, there is vari-
ation in the reported yield of the procedure following a stillbirth
(Gordijn 2002). Furthermore, many factors influence parents’ de-
cision regarding whether to consent to autopsy (Breeze 2012), and
some parents may decline to avoid subjecting their baby to inva-
sive examination (Lyon 2004). Cultural and religious practices,
such as the requirement of prompt burial or for the baby’s body to
be left undisturbed, or both, may also influence decision making
(Gordijn 2007). In many cases, whether to consent to an autopsy
of their baby is one of the most difficult and pressing decisions
facing parents immediately following stillbirth. The information
and counselling parents receive at this time, and their interactions
with care providers, can impact upon their grief and longer-term
psychosocial functioning (Burden 2016;Heazell 2012). Some par-
ents later regret their decision regarding an autopsy of their baby
(Heazell 2012; Rankin 2002), which may only add to parents’
emotional suffering. Despite the need, there are currently no in-
terventions to support parents’ decision making around this pro-
cedure (Horey 2013). Medical personnel are often reluctant to ap-
proach parents about autopsy for various reasons, including emo-
tional burden (Khong 2010; Rose 2006) or because they do not
believe the investigation will yield any new information, or both
(Lyon 2004; Rose 2006). Therefore, when full autopsy is not pos-
sible, alternative investigations such as partial autopsy, minimally
invasive tissue sampling (Castillo 2015), fetal CT scan, fetal ra-
diography (Lim 2005), and fetal MRI (Alderliesten 2003; Arthurs
2015; Thayyil 2013; Vullo 2016) may be performed.
Alongside autopsy, examination of the placenta and testing for
chromosomal abnormalities have shown high value in ascertaining
causes of death (Bukowski 2011;Korteweg2008;Korteweg2012).
Other investigations that may be used in the routine evaluation
of stillbirth include (but are not limited to) maternal thyroid,
liver and kidney function tests, testing for gestational diabetes
(Flenady 2018), toxicology screening (to detect maternal drug
use), and tests for various infections and viruses (Silver 2007).
Investigations to identify maternal antibodies and blood clotting
disorders (thrombophilias) may be informative in some situations.
As stated earlier, the ability to undertake certain investigationsmay
be extremely limited in some settings, due to a lack of resources
and low(er) attendance at health services (Flenady 2010). Financial
costs incurred by health services can be a significant barrier to
performing a thorough investigation following stillbirth. As shown
in a UK study (Mistry 2013), the cost of diagnostic investigations
following stillbirth may as high as GBP 1804 per pregnancy, with
perinatal autopsy being the most costly component. Many such
sophisticated diagnostic investigations are simply unavailable in
LMICs. In these settings, verbal autopsy (involving interviewswith
care providers and support people, without examination of the
baby) may be used as an indirect method of ascertaining cause of
death (Nausheen 2013). Therefore, it is also important to identify
which tests are feasible in a setting where economic cost and access
to equipment are barriers.
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How the intervention might work
A high-quality investigation into the causes of stillbirth will ide-
ally place minimal emotional and financial burden on parents,
staff, and health services, while maintaining high diagnostic yield
(Corabian 2005; Lim 2005; Silver 2007). A number of formal
protocols are currently in use to standardise investigations fol-
lowing stillbirth but, as shown in a systematic review (Corabian
2005), there is large variation in the investigations that may be
recommended. A specific comprehensive investigation protocol
has previously been shown to be cost-effective when incorporated
into routine stillbirth evaluation (Michalski 2002). Comprehen-
sive investigation protocols may be advantageous where there are
multiple, interacting causes which may not otherwise be detected
(Silver 2007). Another approach to the workup of stillbirth is se-
lective testing, where investigations are undertaken based on clin-
ical features and presumed diagnosis (Flenady 2010; Lim 2005).
A selective approach to investigations may reduce economic costs
(Lim 2005), while also minimising the chance of producing inci-
dental positive test results that cause anxiety among parents and
are unhelpful in ascertaining a cause of death (Korteweg 2012;
Silver 2007). Sequential testing, where tests are undertaken based
on the results of other tests, has been proposed as another alter-
native (Flenady 2010; Korteweg 2012). This approach suggests a
platform of basic tests with follow-up investigations undertaken
as indicated (Korteweg 2012). For example, while routine throm-
bophilia testing is not commonly recommended, it may be con-
sidered where there is evidence of placental complications, such as
FGR or placental abruption (Korteweg 2010; Silver 2007).
High-quality tests, protocols or guidelines for investigating and
identifying the causes of stillbirth have the potential to reduce
the number of unexplained deaths and misdiagnosed causes of
death. Investigations may also have value in confirming clinical
diagnoses, providing additional information that may not have
been expected from basic clinical information (Gordijn 2002;
Horn 2004), and excluding specific causes of death (Horn 2004;
Korteweg 2012). Relying solely on death certificates to identify
causes of death is problematic. Death certificates are not required
for stillbirths in many LMICs, and many births occur outside for-
mal health services, and not reported in vital statistics (Flenady
2015). Even in high-income settings, the causes of death docu-
mented on death certificates are frequently inaccurate or incom-
plete (Cockerill 2012;Headley2009;Measey 2007). Retrospective
cohort studies have shown that the proportion of deaths initially
classified as unexplained can be reduced by up to 65% following
investigation and clarification (Headley 2009; Measey 2007).
Accurate identification of causes of stillbirth may not only aid in
emotional closure for parents, it may also provide a platform for
clinical management in subsequent pregnancies (Flenady 2018;
Michalski 2002; Silver 2007). Indeed, the need for information
to plan future pregnancies is one of the most important factors
that influences parents’ decision regarding whether to have an au-
topsy of their baby (Breeze 2012) and is highly likely to affect
their satisfaction with care. The identification of a known recur-
rent cause of death, or an unexplained death despite thorough
investigation, may prompt additional testing and surveillance in
subsequent pregnancies (Mistry 2013). In contrast, the identifi-
cation of a known non-recurrent cause may reassure parents and
spare them from unnecessary testing and intervention in subse-
quent pregnancies (Silver 2007). The Mistry 2013 study showed
pregnancies subsequent to stillbirths that were unexplained or had
known recurrent causes were GBP 500 more costly than pregnan-
cies subsequent to stillbirths due to known non-recurrent causes.
The study suggested that while a comprehensive workup of still-
birth may bring a higher initial cost to health systems, the eco-
nomic costs of care in subsequent pregnancies may be reduced
if investigations can exclude recurrent causes and reduce unex-
plained deaths (Mistry 2013). Importantly, the quality of the post-
mortem investigation and report, regardless of the investigations
performed, will affect the likelihood of yielding clinically mean-
ingful information (Cartlidge 1995; Corabian 2005).
Why it is important to do this review
The prevention of stillbirth requires an understanding of its causes.
Understanding of the causes of stillbirth is also critical to the
psychosocial well-being of bereaved parents, and to the planning
of management of their subsequent pregnancies, including coun-
selling about recurrence risks. Diagnostic investigations aim to
meet these needs, but there is currently no consensus on the op-
timal approach to investigations, including even the most basic
set of key minimal investigations recommended (Korteweg 2012;
Lim 2005). Given the wide variety of investigations that are po-
tentially available, their economic cost, and potential to add fur-
ther to parents’ emotional burden, there is a need to systematically
assess the effect of these interventions on outcomes for families,
including psychosocial outcomes, and on rates of diagnosis of the
causes of stillbirth.
O B J E C T I V E S
To assess the effect of different tests, protocols or guidelines for
investigating and identifying the causes of stillbirth on outcomes
for parents, including psychosocial outcomes, economic costs, and
rates of diagnosis of the causes of stillbirth.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We planned to include randomised controlled trials (RCTs),
quasi-RCTs, and cluster-RCTs. We excluded cross-over trials. We
planned to include studies published as abstract only, provided
there was sufficient information to allow us to assess study eligi-
bility.
Types of participants
We planned to include parents (including mothers, fathers, and
partners) who had experienced a stillbirth of 20 weeks’ gestation
or greater.
Types of interventions
We planned to include trials assessing any test, protocol or guide-
line (or combinations of tests/protocols/guidelines) for investi-
gating the causes of stillbirth, compared with the absence of a
test, protocol or guideline, or usual care (see Description of the
intervention for further details about types of tests or investiga-
tions that might be included in protocols or guidelines).
We also planned to include trials comparing any test, protocol or
guideline (or combinations of tests/protocols/guidelines) for in-
vestigating the causes of stillbirth with another (for example, the
use of a limited investigation protocol compared with a compre-
hensive investigation protocol).
Types of outcome measures
No core outcomes were identified for this review topic. We there-
fore selected a range of important outcomes with respect to the
effects of investigations, as below.
Primary outcomes
• Change in the final cause(s) of death from the presumed or
clinical a priori cause of death.
• Final cause(s) of death unknown.
• Additional parental counselling or subsequent pregnancy
care information (e.g. determination of or change in recurrence
risk; exclusion of suspected causes of death; exclusion of
recurrent causes of death; or combination of these).




• Confirmation of clinical diagnosis.
• Attainment of unexpected findings.
• Exclusion of suspected causes of death.
• Exclusion of recurrent causes of death.
• Compliance with test/protocol/guideline.
• Parental understanding of the cause(s) of death.
• Parental regret about the investigations performed.
• Parental attitudes towards process and outcomes of
investigations.
• Parental psychosocial outcomes including anxiety and
quality of life.
• Parental satisfaction with care around the time of death and
at follow-up.
• Care provider satisfaction with the process and outcomes of
investigations.
• Frequency of investigations performed, e.g. maternal and
family history; maternal investigations prior to birth; stillborn
examination; umbilical cord examination; placental examination.









• Costs of the subsequent pregnancy (economic).
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (31 August 2017).
The Register is a database containing over 23,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ’Specialized Register’ sec-
tion from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
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1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences; and
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results were screened by two review authors and the full
text of all relevant trial reports identified through the searching
activities described above were reviewed. Based on the interven-
tion described, each trial report was assigned a number that cor-
responds to a specific Pregnancy and Childbirth review topic (or
topics), and was then added to the Register. The Information Spe-
cialist searched the Register for each review using this topic num-
ber rather than keywords. This resulted in a more specific search
and any search results would have been fully accounted for in the
relevant review sections (Included, Excluded, Awaiting Classifica-
tion or Ongoing).
In addition, we searched ClinicalTrials.gov and the WHO Inter-
national Clinical Trials Registry Platform ( ICTRP) for unpub-
lished, planned and ongoing trial reports on 15 May 2017 using
the terms in Appendix 1.
Searching other resources
We planned to search the reference lists of retrieved studies for
further eligible studies. We did not apply date or language restric-
tions to any searches.
Data collection and analysis
No eligible studies were identified by the search for this version
of the review, but for future updates, we plan to use the methods
outlined in Appendix 2. These methods are based on a standard
template used by Cochrane Pregnancy and Childbirth.
R E S U L T S
Description of studies
Results of the search
There were no eligible trials identified from the search strategy
within the Cochrane Pregnancy and Childbirth’s Trials Register.
We retrieved 224 records from ClinicalTrials.gov, equating to 152
trials when duplicates were removed.We retrieved 46 records from
ICTRP, equating to 23 trials when duplicates were removed. All
records were screened-out or excluded based on full-text review
(see Figure 1).
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Figure 1. Study flow diagram.
Excluded studies
Five records underwent full-text review and were excluded
based on study design/failure to meet eligibility criteria (see
Characteristics of excluded studies). One of these studies (
Brasseur-Daudruy 2014), a non-randomised trial assessing the ef-
fectiveness of MRI as a diagnostic tool following intrauterine fe-
tal death, has since been discontinued due to low recruitment.
Another non-randomised trial (Rüegger 2014) is currently assess-
ing the yield of minimally invasive or ’virtual autopsy’ (a combi-
nation of postmortem imaging and imaging-guided biopsies) as
compared to conventional autopsy. It is expected that this study
will be completed in 2018.




D I S C U S S I O N
There is currently a lack of randomised controlled trial evidence
regarding the effectiveness of interventions for investigating and
identifying causes of stillbirth. Seeking to understand the causes of
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stillbirth is fundamental to quality maternity care, but it remains
unclear what effect these interventions have on certain outcomes,
including psychosocial outcomes for parents and families, rates of
diagnosis of the causes of stillbirth, and subsequent pregnancy care
and management. This review highlights the challenges clinicians
and researchers face in developing high-quality clinical practice
guidelines to guide the investigation of stillbirths.
On the basis of other literature (assessing non-randomised stud-
ies), fundamental components of the investigation of stillbirths
appear to include comprehensive maternal (medical, social, fam-
ily) and pregnancy history, and external examination of the baby.
Evenwhere not diagnostic in isolation, these investigations may be
highly informative in directing further testing. Perinatal autopsy
is often a highly important investigation (Corabian 2005; Gordijn
2002;Headley 2009; Killeen2004; Korteweg 2012;Measey 2007;
Miller 2016; Page 2017;Rossi 2017), alongside placental examina-
tion and histopathology (Headley 2009; Heazell 2009; Korteweg
2012; Page 2017).Other investigations, including genetic analyses
(Korteweg 2008; Korteweg 2012; Reddy 2012; Rosenfeld 2015)
and tests for the detection of maternal-fetal haemorrhage (the pas-
sage of fetal blood cells into the maternal circulation) (Korteweg
2012; O’Leary 2015; Page 2017; Silver 2007), have also shown
high value in identifying the causes of stillbirths.
Until appropriately designed randomised controlled trials have
been conducted, clinical guidelines regarding approaches to the
investigation of stillbirthmay continue to be based upon the infor-
mation yielded from such existing non-randomised studies, most
of which are specific to high-income countries.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Due to the absence of randomised controlled trials, this review
is unable to inform clinical practice regarding the effectiveness of
interventions for investigating and identifying causes of stillbirth.
Implications for research
High-quality clinical trials are needed to measure the effectiveness
of interventions for investigating and identifying the causes of still-
birth. However, there are difficulties in conducting randomised
trials addressing this research question, due to its ethical and prac-
tical complexities. As such, the design of future trials would need
to be considered carefully, ensuring that the current standard of
care in a given local setting is maintained. It may be appropriate to
evaluate a comprehensive investigation protocol against a selective
protocol where, in the latter, investigations are limited to those
that appear warranted on the basis of clinical history or the sus-
pected diagnosis, or both. Another trial design may involve ran-
domising to a conceal versus reveal protocol, where all pertinent
investigations are carried out (and results shared with parents),
but the information yielded from certain investigations is either
provided or withheld from a panel of experts, depending on the
intervention arm.
With either of the options outlined above, trialists would need to
ensure clinical equipoise in the given approaches to investigation,
both from an ethical standpoint, and to aid in the recruitment of
trial participants. Although itwas excluded from the current review
on the basis of study design, the discontinued Brasseur-Daudruy
2014 trial highlights the difficulties researchers face in recruiting
participants for trials addressing this research question. Therefore,
depending on the setting, the need for clinical equipoise may pre-
clude certain types of intervention arms/investigation protocols,
such as any that were deemed to be at risk of missing an important
diagnosis. Trials evaluating a new investigation protocol against
no intervention may be highly informative, but would only be
feasible and appropriate in settings where no or minimal stillbirth
investigations are currently offered (such as in some low- and mid-
dle-income countries (LMICs)).
Notwithstanding, any such trials must be conducted with the ut-
most care and consideration for the needs, concerns, and values
of parents, and should be designed in such a way to allow fol-
low-up and assessment of longer-term psychosocial variables, eco-
nomic costs to health services, and effects on subsequent preg-
nancy care and outcomes. Effective methods for communicating
with bereaved parents about stillbirth risk factors and recommen-
dations for subsequent pregnancy care, based upon the findings
of investigations, should also be explored.
There remains a place for a series of Cochrane Diagnostic Test
Accuracy reviews in the context of perinatal death, to understand
precisely how well specific diagnostic investigations perform in
their capacity to discriminate accurately between the true pres-
ence and absence of specific conditions (e.g. fetal-maternal haem-
orrhage). For such reviews to be carried out, an appropriate ref-
erence standard would need to be identified and clearly defined.
Such a reference standard might be comprehensive autopsy by a
skilled perinatal pathologist coupled with placental examination
and histopathology. The influence of subjective clinical criteria
for diagnosing certain conditions (e.g. gestational diabetes) should
also be assessed.
New software programs enabling quantitative, objective assess-
ment of placental tissue have been reported (Kidron 2017; Ptacek
2016). The use of image analysis software may provide additional
information to that received from qualitative assessment alone.
Such techniques may assist with standardisation of placental his-
tological examination, but further research into their diagnostic
utility is needed (Kidron 2017). Economic costs and feasibility
also need to be considered. Developing basic minimal practices for
identifying causes of stillbirths in LMICs also remains a priority.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bellver 2010 Non-randomised trial; recurrent spontaneous abortion (defined as first trimester losses of 5 to 14 weeks’
gestation)
Bloemenkamp 2011 Non-randomised trial
Brasseur-Daudruy 2014 Non-randomised trial
Rüegger 2014 Non-randomised trial
Sugiura 2013 Non-randomised trial
A P P E N D I C E S
Appendix 1. Search terms for ICTRP and ClinicalTrials.gov







pregnancy loss AND cause
pregnancy loss AND causes
Appendix 2. Methods to be used in future updates
Selection of studies
Two review authors will independently assess for inclusion all the potential studies we identify as a result of the search strategy. We will
resolve any disagreement through discussion or, if required, we will consult a third review author.
We will create a study flow diagram to map out the number of records identified, included and excluded.
Data extraction and management
We will design a form to extract data. For eligible studies, two review authors will extract the data using the agreed form.We will resolve
discrepancies through discussion or, if required, we will consult a third review author. We will enter data into Review Manager software
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(Review Manager 2014) and check for accuracy. When information regarding any of the above is unclear, we will attempt to contact
authors of the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors will independently assess risk of bias for each study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We will resolve any disagreement by discussion or by involving a third assessor.
1. Random sequence generation (checking for possible selection bias)
We will describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We will assess the method as:
• low risk of bias (any truly random process, e.g. random number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);
• unclear risk of bias.
2. Allocation concealment (checking for possible selection bias)
We will describe for each included study the method used to conceal allocation to interventions prior to assignment and will assess
whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.
We will assess the methods as:
• low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);
• unclear risk of bias.
3.1. Blinding of participants and personnel (checking for possible performance bias)
We will describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which
intervention a participant received. We will consider that studies are at low risk of bias if they were blinded, or if we judge that the lack
of blinding would be unlikely to affect results. We will assess blinding separately for different outcomes or classes of outcomes.
We will assess the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
3.2. Blinding of outcome assessment (checking for possible detection bias)
We will describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a
participant received. We will assess blinding separately for different outcomes or classes of outcomes.
We will assess methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
4. Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete
outcome data)
We will describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We will state whether attrition and exclusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing
data were balanced across groups or were related to outcomes. Where sufficient information is reported, or can be supplied by the trial
authors, we will re-include missing data in the analyses which we undertake.
We will assess methods as:
• low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);
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• high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial
departure of intervention received from that assigned at randomisation);
• unclear risk of bias.
5. Selective reporting (checking for reporting bias)
We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.
We will assess the methods as:
• low risk of bias (where it is clear that all of the study’s pre-specified outcomes and all expected outcomes of interest to the review
have been reported);
• high risk of bias (where not all the study’s pre-specified outcomes have been reported; one or more reported primary outcomes
were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key
outcome that would have been expected to have been reported);
• unclear risk of bias.
6. Other bias (checking for bias due to problems not covered by 1 to 5 above)
We will describe for each included study any important concerns we have about other possible sources of bias.
We will assess whether each study was free of other problems that could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
Assessing the quality of the evidence using the GRADE approach
We will use the GRADE approach as outlined in the GRADE handbook in order to assess the quality of the body of evidence relating
to the following outcomes for the main comparisons:
• change in the final cause(s) of death from the presumed or clinical a priori cause of death;
• final cause(s) of death unknown;
• additional parental counselling or subsequent pregnancy care information (e.g. determination of or change in recurrence risk;
exclusion of suspected causes of death; exclusion of recurrent causes of death; or combination of these);
• parental satisfaction with the process and outcomes of investigations;
• compliance with test/protocol/guideline;
• costs of investigations (economic); and
• stillbirth (in the subsequent pregnancy).
We will use the GRADEpro Guideline Development Tool to import data from Review Manager 5.3 (Review Manager 2014) in order
to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes
will be produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be
downgraded from ’high quality’ by one level for serious (or by two levels for very serious) limitations, depending on assessments for
risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the
standardised mean difference to combine trials that measure the same outcome, but use different methods.
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Unit of analysis issues
Cluster-randomised trials
We will include cluster-randomised trials in the analyses along with individually-randomised trials. We will adjust their sample sizes
using the methods described in the Handbook using an estimate of the intracluster correlation co-efficient (ICC) derived from the
trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this
and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and
individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results
from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice
of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
We plan to include multi-armed trials, ensuring analyses are independent. If multi-armed trials are included, we will split the ‘shared’
group into two or more groups with smaller sample size, and include two or more (reasonably independent) comparisons. Alternatively,
we will combine groups to create a single pair-wise comparison.
Cross-over trials
We will exclude cross-over designs as these are unlikely to be a valid study design for Pregnancy and Childbirth reviews.
Dealing with missing data
For included studies, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in
the overall assessment of treatment effect by using sensitivity analysis.
For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to include all participants
randomised to each group in the analyses, and all participants will be analysed in the group to which they were allocated, regardless of
whether or not they received the allocated intervention. The denominator for each outcome in each trial will be the number randomised
minus any participants whose outcomes are known to be missing.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We will regard heterogeneity as
substantial if an I² is greater than 30% and either the Tau² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test
for heterogeneity.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots.
We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses
to investigate it.
Data synthesis
We will carry out statistical analysis using the Review Manager software (Review Manager 2014). We will use fixed-effect meta-analysis
for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are
examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there is clinical heterogeneity
sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we
will use random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials is considered clinically
meaningful. The random-effects summary will be treated as the average of the range of possible treatment effects and we will discuss
the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will
not combine trials.
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If we use random-effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the
estimates of Tau² and I².
We plan to consider separately those trials assessing any test/protocol or guideline (or combinations of tests/protocols/guidelines)
compared with no test/protocol/guideline or usual care, and those comparing different tests/protocols/guidelines.
Subgroup analysis and investigation of heterogeneity
If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether
an overall summary is meaningful, and if it is, use random-effects analysis to produce it.
We plan to carry out the following subgroup analyses across the primary outcomes:
• number and type of investigations included in the protocol/guideline (e.g. single/limited investigation(s) recommended versus
multiple/comprehensive investigations recommended);
• quality of the autopsy/postmortem report (e.g. low quality versus high quality, or not meeting a minimum standard versus
meeting a minimum standard);
• presumed cause(s) of death prior to investigations: unexplained stillbirth at time of death versus stillbirth with known/presumed
cause(s);
• gestational age at death: death at less than 28 weeks’ gestation versus at 28 weeks’ gestation or greater;
• setting: low- and middle-income countries versus high-income countries; and
• classification systems used.
We will assess subgroup differences by interaction tests available within RevMan (Review Manager 2014). We will report the results of
subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.
Sensitivity analysis
Sensitivity analyses will be conducted to explore the effects of trial quality and trial design on the outcomes. We will explore the effects
of trial quality assessed by allocation concealment and random sequence generation (considering selection bias), by omitting studies
rated as ’high risk of bias’ (including quasi-randomised trials) or ’unclear risk of bias’ for these components.
We will investigate the effects of the randomisation unit (individual versus cluster) on the outcomes, and the impact of including studies
with high levels of missing data. We will explore the effects of fixed-effect or random-effects analyses for outcomes with statistical
heterogeneity, and the effects of any assumptions made such as the value of the ICC used for cluster-randomised trials.
We will use primary outcomes in sensitivity analyses.
C O N T R I B U T I O N S O F A U T H O R S
Aleena M Wojcieszek led the drafting of the review with contributions from all authors, including methodological input provided by
Vicki Flenady, PhilippaMiddleton and Emily Shepherd, and content input provided by Vicki Flenady and Katherine J Gold. AleenaM
Wojcieszek and Emily Shepherd undertook screening of search records. Vicki Flenady, Philippa Middleton, and Aleena M Wojcieszek
designed the protocol with contribution from all authors.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Any differences between the published protocol for this review (Wojcieszek 2017) and this full review are listed below.
Additional terms for ICTRP and ClinicalTrials.gov searches (see Appendix 1).
The secondary outcome ’costs of investigations’ has been edited to ’Costs of investigations (economic)’.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Stillbirth; Cause of Death
MeSH check words
Female; Humans; Pregnancy
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